Table 1.
Multivariate analysis of ABCB1 expression in the chemotherapy-led CNS9204 trial.
| Survival | Factor | Hazard Ratio (95% confidence interval) | P value |
|---|---|---|---|
| Event-Free Survival (EFS) | ABCB1 expression (Positive vs. Negative) | 2.79 (1.33–5.87) | 0.007 |
| Resection (Incomplete vs. Complete) | 1.32 (0.67–2.74) | 0.39 | |
| WHO Grade (Grade III Vs. Grade II) | 1.06 (0.54–2.12) | 0.84 | |
| Overall Survival (OS) | ABCB1 expression (Positive vs. Negative) | 3.0 (1.32–6.81) | 0.008 |
| Resection (Incomplete vs. Complete) | 1.32 (0.58–3.0) | 0.71 | |
| WHO Grade (Grade III vs. Grade II) | 1.16(0.52–2.60) | 0.49 |